Who We Are
Haynes and Boone’s Healthcare, Life Sciences and Pharmaceuticals Practice Groups work with clients across all sectors of the diverse healthcare industry to address their legal needs, including business transactions, regulatory compliance, government investigations, and patent litigation and counseling.
At Haynes and Boone, we believe experience and creativity are key qualities for success in the constantly changing legal landscape of life sciences, pharmaceuticals, and healthcare. Often the best result comes from collaboration of lawyers with varied experience who together provide the right combination of knowledge and ideas for your business. Our philosophy is to use teamwork to provide our clients with innovative options to the legal opportunities in their business.
Our lawyers have experience in the following areas.
The False Claims Act, 31 U.S.C. §§ 3729, et seq. (FCA) continued to be a significant focus of government and whistleblower activity in 2016. This Year in Review highlights several key developments.
The Haynes and Boone Health Law Vitals Newsletter explores significant developments and legislation in healthcare law. This edition discusses the final guidance on medical device reporting requirements, an update on telemedicine in Texas, the FDA's guidance on lead in cosmetics, and more.
Biotechnology, pharmaceutical and medical device companies are likely to pick up the pace of dealmaking in 2017, according to a recent survey of life sciences industry leaders conducted by law firm Haynes and Boone...
Sending an email will not establish an attorney-client relationship. You should not send us any information that you want treated confidentially. By clicking Accept you acknowledge that we may review and use any information you transmit to us.